Trials / Completed
CompletedNCT07267312
Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome
Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome: A Tertiary Cardiac Center Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to explore the relationship between familial hypercholesterolemia and premature coronary artery disease, particularly in the context of acute coronary syndrome, by reviewing current evidence and highlighting the need for improved screening and aggressive lipid-lowering strategies in high-risk populations.
Detailed description
Dyslipidaemia and familial hypercholesterolemia (FH) are a common disorder that causes premature coronary artery disease. The lifelong burden of elevated low-density lipoprotein cholesterol (LDL-C) in FH accelerates endothelial dysfunction and plaque formation, often culminating in acute coronary syndrome (ACS) at a young age. ACS in patients with undiagnosed FH may be their first clinical manifestation, underscoring the importance of early identification and intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cardiovascular risk assessment | Participants underwent a standardized cardiovascular risk assessment that included detailed clinical evaluation, lipid profiling (Total Cholesterol, Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, and Triglycerides). |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2025-03-27
- Completion
- 2025-03-27
- First posted
- 2025-12-05
- Last updated
- 2025-12-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07267312. Inclusion in this directory is not an endorsement.